PTSD

ptsd-psilocin

Enhancer boosts psilocin potential in psychedelic therapy to treat PTSD

Canadian company NeuroPharm Inc. files application with the U.S. Patent and Trademark Office in connection with a psychedelic therapy.

0
PTSD

MDMA shows potential in PTSD treatment; more research needed on other psychedelics

Australian researchers review the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder

0

Growing body of research shows patients with addiction, PTSD, and depression can benefit from psychedelic substances

Numinus Wellness chief medical officer Dr. Evan Wood cautions that it’s not a cure for everybody—but trials have shown statistically significant results

0

Cusp of breakthrough: clinical trial data suggest efficacy of MDMA therapy for PTSD

Clinical trials of MDMA psychotherapy are going on at 15 sites in the U.S., Canada, and Israel

0